Oui Therapeutics is built on science shown to help people manage troubling thoughts.
Oui Therapeutics has raised $26.0M in total funding. The most recent round was Series A. The last funding was announced in August 2022.
Oui Therapeutics's investors include First Round Capital, Polaris Partners, CVS Health, Flare Capital Partners, Otsuka Holdings.
Oui Therapeutics is headquartered in New Haven, United States.
Oui Therapeutics is built on science shown to help people manage troubling thoughts.
Oui Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oui Therapeutics — Funding & Investors." VCBacked, August 2, 2022, https://www.vcbacked.co/company/oui-therapeutics. Accessed September 29, 2026.
VCBacked. (2022). Oui Therapeutics — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/oui-therapeutics
{{cite web |title=Oui Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/oui-therapeutics |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated